Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordi Bruix

Showing results (1-10 of 291) with videos related to

Pageof 30
Sort By:
Clinical Liver Disease|May 6, 2024
A history of the treatment of primary liver cancerJordi Bruix
Hepatic Oncology|September 8, 2018
Regorafenib and the RESORCE trial: a new second-line option for hepatocellular carcinoma patientsJordi Bruix
Gastroenterologia Y Hepatologia|August 5, 2014
[Usefulness of the molecular profile in the diagnosis, prognosis and treatment of hepatocellular carcinoma]Jordi Bruix
Seminars in Liver Disease|November 5, 2014
Hepatocellular carcinoma: paving the road for further developmentsJordi Bruix
Hepatology (Baltimore, Md.)|June 29, 2011
Liver cancer: still a long way to goJordi Bruix
Journal of Hepatology|February 8, 2021
Endpoints in clinical trials for liver cancer and their value in evidence-based clinical decision making: An unresolved Gordian knotJordi Bruix
Hepatology (Baltimore, Md.)|March 28, 2008
Liver cancer: An evolving challenge reaching research maturityJordi Bruix
Hepatology (Baltimore, Md.)|November 26, 2009
The need for novel and interesting data in liver cancer researchJordi Bruix, Keith Lindor
Journal of Hepatology|November 22, 2005
Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipientsMaria Varela, Jordi Bruix
Hepatology (Baltimore, Md.)|December 25, 2009
Multifaceted perspective of the waiting list for liver transplantation: the value of pharmacokinetic modelsMiquel Navasa, Jordi Bruix
Pageof 30

Showing results (1-10 of 291) with videos related to

Sort By:
Pageof 30
Clinical Liver Disease|May 6, 2024
A history of the treatment of primary liver cancerJordi Bruix
Hepatic Oncology|September 8, 2018
Regorafenib and the RESORCE trial: a new second-line option for hepatocellular carcinoma patientsJordi Bruix
Gastroenterologia Y Hepatologia|August 5, 2014
[Usefulness of the molecular profile in the diagnosis, prognosis and treatment of hepatocellular carcinoma]Jordi Bruix
Seminars in Liver Disease|November 5, 2014
Hepatocellular carcinoma: paving the road for further developmentsJordi Bruix
Hepatology (Baltimore, Md.)|June 29, 2011
Liver cancer: still a long way to goJordi Bruix
Journal of Hepatology|February 8, 2021
Endpoints in clinical trials for liver cancer and their value in evidence-based clinical decision making: An unresolved Gordian knotJordi Bruix
Hepatology (Baltimore, Md.)|March 28, 2008
Liver cancer: An evolving challenge reaching research maturityJordi Bruix
Hepatology (Baltimore, Md.)|November 26, 2009
The need for novel and interesting data in liver cancer researchJordi Bruix, Keith Lindor
Journal of Hepatology|November 22, 2005
Hepatocellular carcinoma in the United States. Lessons from a population-based study in Medicare recipientsMaria Varela, Jordi Bruix
Hepatology (Baltimore, Md.)|December 25, 2009
Multifaceted perspective of the waiting list for liver transplantation: the value of pharmacokinetic modelsMiquel Navasa, Jordi Bruix
Pageof 30